• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌的营养治疗

Nutritional therapy for hepatocellular carcinoma.

作者信息

Ruiz-Margáin Astrid, Román-Calleja Berenice M, Moreno-Guillén Paulina, González-Regueiro José A, Kúsulas-Delint Deyanira, Campos-Murguía Alejandro, Flores-García Nayelli C, Macías-Rodríguez Ricardo Ulises

机构信息

Liver Nutrition Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.

Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.

出版信息

World J Gastrointest Oncol. 2021 Oct 15;13(10):1440-1452. doi: 10.4251/wjgo.v13.i10.1440.

DOI:10.4251/wjgo.v13.i10.1440
PMID:34721776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8529929/
Abstract

Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutritional risk factors also related to HCC development including high intake of saturated fats derived from red meat, type of cooking (generation of heterocyclic amines) and contamination of foods with aflatoxins. On the contrary, protective nutritional factors include diets rich in fiber, fruits and vegetables, n-3 polyunsaturated fatty acids and coffee. While the patient is being evaluated for staging and treatment of HCC, special attention should be paid to nutritional support, including proper nutritional assessment and therapy by a multidisciplinary team. It must be considered that these patients usually develop HCC on top of long-lasting cirrhosis, and therefore they could present with severe malnutrition. Cirrhosis-related complications should be properly addressed and considered for nutritional care. In addition to traditional methods, functional testing, phase angle and computed tomography scan derived skeletal muscle index-L3 are among the most useful tools for nutritional assessment. Nutritional therapy should be centered on providing enough energy and protein to manage the increased requirements of both cirrhosis and cancer. Supplementation with branched-chain amino acids is also recommended as it improves response to treatment, nutritional status and survival, and finally physical exercise must be encouraged and adapted to individual needs.

摘要

肝细胞癌(HCC)是最常见的原发性肝癌,多数情况下与肝硬化并存。除了公认的HCC发生风险因素,如乙型肝炎病毒/丙型肝炎病毒感染、年龄以及酒精/烟草消费外,还有与HCC发生相关的营养风险因素,包括红肉中饱和脂肪的高摄入量、烹饪方式(杂环胺的产生)以及食物被黄曲霉毒素污染。相反,具有保护作用的营养因素包括富含纤维、水果和蔬菜的饮食、n-3多不饱和脂肪酸以及咖啡。在对HCC患者进行分期评估和治疗时,应特别关注营养支持,包括由多学科团队进行适当的营养评估和治疗。必须认识到,这些患者通常在长期肝硬化的基础上发生HCC,因此可能存在严重营养不良。应妥善处理与肝硬化相关的并发症,并在营养护理中予以考虑。除传统方法外,功能测试、相位角以及计算机断层扫描得出的第三腰椎骨骼肌指数是营养评估最有用的工具之一。营养治疗应以提供足够的能量和蛋白质为核心,以满足肝硬化和癌症增加的需求。还建议补充支链氨基酸,因为它能改善治疗反应、营养状况和生存率,最后必须鼓励体育锻炼并使其适应个体需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/8529929/58b747e86314/WJGO-13-1440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/8529929/7af51e86fd6d/WJGO-13-1440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/8529929/58b747e86314/WJGO-13-1440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/8529929/7af51e86fd6d/WJGO-13-1440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/8529929/58b747e86314/WJGO-13-1440-g002.jpg

相似文献

1
Nutritional therapy for hepatocellular carcinoma.肝细胞癌的营养治疗
World J Gastrointest Oncol. 2021 Oct 15;13(10):1440-1452. doi: 10.4251/wjgo.v13.i10.1440.
2
[Nutritional Care in Acute and Chronic Illness].[急慢性疾病中的营养护理]
Hu Li Za Zhi. 2021 Jun;68(3):4-6. doi: 10.6224/JN.202106_68(3).01.
3
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management.肝细胞癌中的肌肉减少症:发病机制与管理。
Chemotherapy. 2022;67(3):152-163. doi: 10.1159/000521741. Epub 2021 Dec 31.
4
Current Medical Treatment for Alcohol-Associated Liver Disease.酒精性肝病的当前医学治疗方法。
J Clin Exp Hepatol. 2022 Sep-Oct;12(5):1333-1348. doi: 10.1016/j.jceh.2022.02.001. Epub 2022 Feb 12.
5
Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.综述文章:肝硬化患者的营养不良/肌肉减少症和衰弱。
Aliment Pharmacol Ther. 2020 Jan;51(1):64-77. doi: 10.1111/apt.15571. Epub 2019 Nov 8.
6
Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis.高蛋白、高纤维饮食加支链氨基酸补充剂对肝硬化患者营养状况的影响。
Rev Gastroenterol Mex (Engl Ed). 2018 Jan-Mar;83(1):9-15. doi: 10.1016/j.rgmx.2017.02.005. Epub 2017 Apr 11.
7
[Liver cirrhosis and encephalopathy: clinical and metabolic consequences and nutritional support].[肝硬化与肝性脑病:临床及代谢后果与营养支持]
Nutr Hosp. 2008 May;23 Suppl 2:8-18.
8
9
Dietary management and supplementation with branched-chain amino acids in cirrhosis of the liver.肝脏肝硬化的饮食管理及支链氨基酸补充
Rev Gastroenterol Mex (Engl Ed). 2018 Oct-Dec;83(4):424-433. doi: 10.1016/j.rgmx.2018.05.006. Epub 2018 Oct 3.
10
HCC, diet and metabolic factors: Diet and HCC.肝癌、饮食与代谢因素:饮食与肝癌
Hepat Mon. 2011 Mar;11(3):159-62.

引用本文的文献

1
Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.肝癌中的基因组改变与微生物群串扰:肿瘤发生与治疗中的肠-肝轴
Genes (Basel). 2025 Jul 30;16(8):920. doi: 10.3390/genes16080920.
2
Systemic complications and management strategies in liver cancer patients undergoing interventional therapy.肝癌介入治疗患者的全身并发症及管理策略
World J Gastrointest Surg. 2025 Jun 27;17(6):104883. doi: 10.4240/wjgs.v17.i6.104883.
3
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy.

本文引用的文献

1
Effect of non-alcoholic beer, diet and exercise on endothelial function, nutrition and quality of life in patients with cirrhosis.非酒精性啤酒、饮食和运动对肝硬化患者内皮功能、营养及生活质量的影响。
World J Hepatol. 2020 Dec 27;12(12):1299-1313. doi: 10.4254/wjh.v12.i12.1299.
2
Association of Processed Meats and Alcohol Consumption with Renal Cell Carcinoma: A Worldwide Population-Based Study.加工肉类和酒精摄入与肾细胞癌的关联:一项全球基于人群的研究。
Nutr Cancer. 2021;73(11-12):2665-2670. doi: 10.1080/01635581.2020.1856388. Epub 2020 Dec 7.
3
Effects of branched-chain amino acids on postoperative tumor recurrence in patients undergoing curative resection for hepatocellular carcinoma: A randomized clinical trial.
肝细胞癌中的免疫微环境:从发病机制到免疫治疗
Cell Mol Immunol. 2025 Jun 11. doi: 10.1038/s41423-025-01308-4.
4
Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation.肠道微生物群与肝细胞癌:代谢产物与免疫治疗调节
Cancer Med. 2025 May;14(9):e70914. doi: 10.1002/cam4.70914.
5
Comprehensive influence of individualized nutrition support and nursing strategy on rehabilitation of patients with liver cancer after operation.个体化营养支持及护理策略对肝癌术后患者康复的综合影响
World J Gastrointest Surg. 2025 Feb 27;17(2):101297. doi: 10.4240/wjgs.v17.i2.101297.
6
Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide.晚期肝细胞癌的管理:综述与实用指南
JCO Oncol Pract. 2025 Mar 3:OP2400872. doi: 10.1200/OP-24-00872.
7
Reduced muscle mass is an important part of Global Leadership Initiative on Malnutrition criteria in nutritional diagnosis of hepatocellular carcinoma.肌肉减少症是全球营养不足倡议营养不良诊断标准中肝癌营养诊断的重要组成部分。
BMC Gastroenterol. 2024 Oct 10;24(1):358. doi: 10.1186/s12876-024-03438-x.
8
Advancements in nutritional diagnosis and support strategies during the perioperative period for patients with liver cancer.肝癌患者围手术期营养诊断与支持策略的进展
World J Gastrointest Surg. 2024 Aug 27;16(8):2409-2425. doi: 10.4240/wjgs.v16.i8.2409.
9
Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation.肝细胞癌中的咖啡因:细胞实验、动物实验及流行病学调查
J Inflamm Res. 2024 Mar 11;17:1589-1605. doi: 10.2147/JIR.S424384. eCollection 2024.
10
The Influence of Diet and Its Components on the Development and Prevention of Hepatocellular Carcinoma (HCC).饮食及其成分对肝细胞癌(HCC)发生发展和预防的影响。
Cancers (Basel). 2024 Mar 2;16(5):1030. doi: 10.3390/cancers16051030.
支链氨基酸对接受根治性切除术治疗的肝细胞癌患者术后肿瘤复发的影响:一项随机临床试验。
J Hepatobiliary Pancreat Sci. 2020 Nov;27(11):819-829. doi: 10.1002/jhbp.830. Epub 2020 Oct 8.
4
Phase Angle From Bioelectrical Impedance for the Assessment of Sarcopenia in Cirrhosis With or Without Ascites.基于生物电阻抗的相位角评估肝硬化伴或不伴腹水患者的肌肉减少症。
Clin Gastroenterol Hepatol. 2021 Sep;19(9):1941-1949.e2. doi: 10.1016/j.cgh.2020.08.066. Epub 2020 Sep 2.
5
Milan criteria in the MELD era-is it justifiable to extend the limits for orthotopic liver transplantation?MELD时代的米兰标准——扩大原位肝移植的标准限制是否合理?
World J Surg Oncol. 2020 Jul 7;18(1):158. doi: 10.1186/s12957-020-01932-6.
6
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.患有MAFLD的年轻患者患重症COVID-19疾病的风险增加:一项多中心初步分析。
J Hepatol. 2020 Sep;73(3):719-721. doi: 10.1016/j.jhep.2020.04.027. Epub 2020 Apr 26.
7
Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma.自噬:多酚在肝细胞癌中的潜在治疗靶点
Cancers (Basel). 2020 Feb 29;12(3):562. doi: 10.3390/cancers12030562.
8
Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area.钇-90 放射性栓塞治疗肝细胞癌:基于 MRI 计算的去脂肌肉面积对预后的预测价值。
Eur J Radiol. 2020 Apr;125:108889. doi: 10.1016/j.ejrad.2020.108889. Epub 2020 Feb 12.
9
Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.基于家庭的体力活动和饮食干预改善晚期肝病患者的身体功能:一项随机先导试验。
Dig Dis Sci. 2020 Nov;65(11):3350-3359. doi: 10.1007/s10620-019-06034-2. Epub 2020 Jan 6.
10
Hepatocellular carcinoma and non-alcoholic fatty liver disease.肝细胞癌与非酒精性脂肪性肝病。
Hepatol Int. 2019 Nov;13(6):688-694. doi: 10.1007/s12072-019-09995-8. Epub 2019 Nov 7.